Παρασκευή, 26 Αυγούστου 2016

Staged Reconstruction of the Inferior Vena Cava After Gunshot Injury

Penetrating injuries with transection of the inferior vena cava carry a high mortality. In a hemodynamically unstable patient, ligation of the vena cava often becomes necessary. The aim of this case report is to describe a delayed reconstruction after stabilization of the patient.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bV4SSq

Long-term Survival in Patients With Descending Thoracic Aortic Aneurysms Treated With Open or Endovascular Surgery at a Single Tertiary Center From 1984 to 2014

Long-term survival in patients treated for descending thoracic aortic aneurysms (TAAs) is unknown, but expected survival affects surgical decision-making. We studied all patients treated for TAA at a single tertiary center from 1984 to 2014 to determine long-term survival after surgery.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bDelQg

Contents



from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bV51oE

Poor Outcomes in Obese Patients After Mesenteric Revascularization for Chronic Mesenteric Ischemia

Patients with chronic mesenteric ischemia (CMI) are traditionally thought of as having a low body mass index (BMI); however with the recent obesity epidemic, many of these patients have higher BMIs. We aimed to evaluate the impact that BMI has on early and late outcomes after mesenteric revascularization (MR) for CMI.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bDfck5

Nicotine Dependence and Willingness to Quit Smoking in Vascular Surgery Patients

Smoking rates have declined; however, it remains the primary modifiable risk factor for vascular disease. Whereas vascular surgeons often advise patients to quit, few provide assistance. We sought to understand patients' interest in quitting and to determine factors that influence this willingness to quit.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bV4Qdg

Cholesterol Lowering in Intermediate-Risk Persons Without Cardiovascular Disease

Treatment with rosuvastatin at a dose of 10 mg per day results in a significantly lower risk of cardiovascular events than placebo in an intermediate-risk, ethnically diverse, population without cardiovascular disease.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bDfaIR

Bioengineered Human Acellular Vessels for Dialysis Access in Patients With End-Stage Renal Disease: Two Phase 2 Single-Arm Trials

Bioengineered human acellular vessels provide safe and functional hemodialysis access.

from Vascular and Endovascular Surgery via xlomafota13 on Inoreader http://ift.tt/2bV5mHX